Literature DB >> 4062090

Bradycardia induced by interaction between quinidine and ophthalmic timolol.

Y Dinai, M Sharir, N Naveh, H Halkin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 4062090     DOI： 10.7326/0003-4819-103-6-890

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  5 in total

1.  Timolol metabolism and debrisoquine oxidation polymorphism: a population study.

Authors:  M S Lennard; R V Lewis; L A Brawn; G T Tucker; L E Ramsay; P R Jackson; H F Woods
Journal:  Br J Clin Pharmacol       Date:  1989-04       Impact factor: 4.335

2.  Meta-analysis of randomised controlled trials comparing latanoprost with timolol in the treatment of patients with open angle glaucoma or ocular hypertension.

Authors:  W Y Zhang; A L Po; H S Dua; A Azuara-Blanco
Journal:  Br J Ophthalmol       Date:  2001-08       Impact factor: 4.638

Review 3.  Genetically determined adverse drug reactions involving metabolism.

Authors:  M S Lennard
Journal:  Drug Saf       Date:  1993-07       Impact factor: 5.606

Review 4.  Systemic adverse effects of topical ophthalmic agents. Implications for older patients.

Authors:  J P Diamond
Journal:  Drugs Aging       Date:  1997-11       Impact factor: 3.923

Review 5.  Current concepts of pharmacotherapy in hypertension--ophthalmically administered beta blockers and their cardiopulmonary effects.

Authors:  D A Sica
Journal:  J Clin Hypertens (Greenwich)       Date:  2001 May-Jun       Impact factor: 3.738
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.